The Federal Trade Commission (FTC) has released a new interactive tool on its website, with help from the Office of National Coordinator for Health Information Technology (ONC), Office for Civil Rights (OCR) and the Food and Drug Administration (FDA), to help health app developers to determine whether certain regulations apply to their app.
“Mobile app developers need clear information about the...
About five months after the Federal Trade Commission (FTC) first charged the marketers of a vision improvement app, called UltimEyes, with deceptively claiming their program was scientifically proven to improve the user's eye sight, the FTC has approved a final consent order that requires the company to stop making these claims.
Carrot Neurotechnology, the company behind the UltimEyes, charges $9...
The Federal Trade Commission (FTC) has charged the marketers of a vision improvement app, called UltimEyes, with deceptively claiming they their program was scientifically proven to improve the user's eye sight. The company behind the app, Carrot Neurotechnology, and its co-owners Adam Goldberg and Aaron Seitz have agreed to pay $150,000 and to stop citing the claims. Notably, the $5.99 app is...
by Bradley Merrill Thompson
As just about everyone knows, last week the FDA published its final guidance on mobile medical apps. That guidance explains in plain English the types of mHealth apps the agency regulates. Over the coming weeks, many of us will be dissecting that guidance to assess what it really means and how the guidance affects the numerous apps already released, as well as those on...
Will Falk of PricewaterhouseCoopers
Mobile health, digital health, wireless health and telehealth, meet virtual health. That's the umbrella term preferred by Will Falk, managing partner for healthcare at PricewaterhouseCoopers Canada and executive fellow at the Mowat Centre for Policy Innovation in Toronto, who believes that virtual care is slowly taking over medicine.
"The virtualization of...
